High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers

Purpose: Colorectal cancer is the third most common cancer and also the fourth most common cause of cancer mortality worldwide. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage II/III rectal cancer....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cancer
Prif Awduron: Lin, Shih-Chun, Chang, I-Wei, Hsieh, Pei-Ling, Lin, Ching-Yih, Sun, Ding-Ping, Sheu, Ming-Jen, Yang, Ching-Chieh, Lin, Li-Ching, He, Hong-Lin, Tian, Yu-Feng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ivyspring International Publisher 2017
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604207/
https://ncbi.nlm.nih.gov/pubmed/28928864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19545
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg